Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|December 19, 2007
Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysisMunir Pirmohamed, Julian B Arbuckle, Clive E Bowman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 6, 2016
A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's DiseaseMichael W Lutz, Scott S Sundseth, Daniel K Burns, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 16, 2019
Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level-dependent functional magnetic resonance imaging study in elderly adultsAnnchen R Knodt, James R Burke, Kathleen A Welsh-Bohmer, et al.
Current Opinion in Pharmacology|February 26, 2014
New applications of disease genetics and pharmacogenetics to drug developmentAllen D Roses, Ann M Saunders, Michael W Lutz, et al.
Neurology|January 22, 2017
TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotypeLei Yu, Michael W Lutz, Robert S Wilson, et al.
Frontiers in Neuroscience|February 22, 2020
Structural Variants May Be a Source of Missing Heritability in sALSFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Characterization of APOE and TOMM40 allele frequencies in the Japanese populationAkira Nishimura, Hidenori Nonomura, Shingo Tanaka, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2017
Neuropathologic features of TOMM40 '523 variant on late-life cognitive declineLei Yu, Michael W Lutz, Jose M Farfel, et al.
Pageof 3